Related Experiment Video
Updated: Aug 7, 2025

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Pathways of Coagulopathy and Inflammatory Response in SARS-CoV-2 Infection among Type 2 Diabetic Patients
Orsolya-Zsuzsa Akácsos-Szász1, Sándor Pál2, Kinga-Ilona Nyulas1
1Doctoral School, Faculty of Medicine, George Emil Palade University of Medicine Pharmacy, Science, and Technology of Târgu Mureş, 540142 Târgu-Mureș, Romania.
Insights
Diabetic patients with COVID-19 face high mortality due to blood clots. This review details the complex mechanisms linking diabetes, inflammation, and COVID-19-related coagulopathy for better patient management.
Area of Science:
- Cardiovascular Medicine
- Infectious Diseases
- Endocrinology
Background:
- Diabetic patients exhibit chronic inflammation and endothelial dysfunction.
- COVID-19 infection exacerbates these conditions, leading to increased mortality, particularly from thromboembolic events.
- Diabetes mellitus is a significant risk factor for severe COVID-19 outcomes.
Purpose of the Study:
- To elucidate the underlying pathomechanisms of COVID-19-related coagulopathy in diabetic patients.
- To synthesize current scientific understanding of the interplay between diabetes and SARS-CoV-2 infection concerning vascular and clotting disorders.
- To identify key factors contributing to arteriopathy and thrombosis in this vulnerable population.
Main Methods:
- Systematic literature review and data synthesis.
- Comprehensive search of scientific databases including Cochrane, PubMed, and Embase.
- Analysis of recent research on COVID-19, diabetes, and coagulopathy.
Main Results:
- Detailed presentation of complex interrelations between various factors and pathways involved in arteriopathy and thrombosis.
- Identification of genetic and metabolic factors influencing COVID-19 course in diabetic individuals.
- Elucidation of SARS-CoV-2-related vasculopathy and coagulopathy mechanisms in diabetes.
Conclusions:
- Understanding these pathomechanisms is crucial for managing COVID-19 in diabetic patients.
- Enhanced knowledge facilitates improved diagnostic and therapeutic strategies for this high-risk group.
- This review provides a foundation for more effective clinical management of COVID-19-associated coagulopathy in diabetes.
Abstract:
Chronic inflammation and endothelium dysfunction are present in diabetic patients. COVID-19 has a high mortality rate in association with diabetes, partially due to the development of thromboembolic events in the context of coronavirus infection. The purpose of this review is to present the most important underlying pathomechanisms in the development of COVID-19-related coagulopathy in diabetic patients. The methodology consisted of data collection and synthesis from the recent scientific literature by accessing different databases (Cochrane, PubMed, Embase). The main results are the comprehensive and detailed presentation of the very complex interrelations between different factors and pathways involved in the development of arteriopathy and thrombosis in COVID-19-infected diabetic patients. Several genetic and metabolic factors influence the course of COVID-19 within the background of diabetes mellitus. Extensive knowledge of the underlying pathomechanisms of SARS-CoV-2-related vasculopathy and coagulopathy in diabetic subjects contributes to a better understanding of the manifestations in this highly vulnerable group of patients; thus, they can benefit from a modern, more efficient approach regarding diagnostic and therapeutic management.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Psychoneuroimmunology: Diabetes and Cancer
Coronary Artery Disease I: Introduction

